Spain is moving forward with a framework for medical cannabis usage after delays due to a general election. The draft ...

Trevi Therapeutics has achieved key milestones in its clinical programs for Haduvio (nalbuphine), a treatment targeting ...

Italian pharma major Recordati saw its shares rise more than 5% to 52.00 euros in early trading, as it announced a deal to ...

Kurma Partners has raised €140 million ($154 million) in the first closing of its Biofund IV, with a target of €250 million ...

The European Medicines Agency’s pharmacovigilance committee, PRAC, has started a review of medicines containing finasteride ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Sirnaomics has entered a subscription agreement with biotech specialist Poon Hung Fai, who will acquire over 17.5 million ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...

Aspire Pharma, a UK-based niche generics firm, has acquired all assets from Canute Pharma, expanding its product range and ...